CASE STUDIES OF ALLIANCE CONTRACT PHARMA
Expertise, dedication, quality, cost effective and speed. In the health care industry, these values are commonly stated but not often achieved. Alliance Contract Pharma is a proven exception to the rule. Their steadfast commitment to each customer relationship is the reason drug developers engage ACP to solve problems and deliver innovative results.
A leading developer of novel cancer therapeutics was experiencing persistent manufacturing process issues. Their contract manufacturing partners were unable to deliver a consistent process for liquid filled capsules which resulted in the loss of very expensive batches of product. To make matters worse, their technicians and engineers were unable to develop a solution because they couldn’t accurately diagnose the problem. They tried to outsource diagnosis and resolution to half a dozen larger CMOs, each without success, when finally, they turned to Alliance Contract Pharma.
Alliance Contract Pharma had extensive experience working with virtual, small, and mid-sized pharma companies, with particular expertise in liquid filled capsules of API in suspensions. ACP’s engineers were able to determine the cause of the two different problems.
The first problem was the hydrophobic nature of the API and the interaction with the capsule banding material. Working closely with the client and the manufacturer of the equipment, ACP was able to develop an “out of the box” solution for the application of the banding material to the capsule.
The second problem was the excessively high viscosity of the suspension rendering the suspension too thick to fill into the capsules through the conventional equipment. In addition to diagnosing this problem, ACP was able to develop a solution and engineer custom parts to support the new process, creating a specialized fill nozzle to appropriately aid delivery of the suspension into the capsule.
With ACP, this developer now has a collaborative partner on their team. They know that ACP is an expert in identifying issues during the manufacturing process, and taking quick, intelligent actions to minimize potential product and monetary losses.
In addition, ACP is capable of engineering customized equipment which also aids in solving future problems, reducing potential product waste, and saving time and money on future batches. The drug developer experienced the genuine care that everyone at ACP has for their clients and their clients’ molecular products along with the expertise to quickly and cost effectively deliver innovative results. Alliance Contract Pharma is honored to collaborate to help make this leading cancer therapeutic drug developer successful.
Contact Alliance Contract Pharma today to see how we can help meet your needs and improve your bottom line.